ID    AVR/I/SSAP112
ET    Clinical
PN    RMAD-4
PL    32 [Note: any special compound, if present in sequence, is not considered in length]
SR    myeloid a-defensin
SO    Rhesus macaque
TX    Animalia (Rhesus monkey)
VL    Experimentally validated
XX
TO    Mu3 (hVISA) (clinical bacterial isolate obtained from hospitalized patients at Huntington Hospital (Pasadena, CA, USA))
IC    MBC = 3 microM
TH    RMAD-4, along with Crp-4 and RTD-1, are non-hemolytic peptides. Systemic administration of RMAD-4 to BALB/c mice was non-toxic and stable in serum and plasma, indicating its safety profile in vivo.
XR    PubMed: 24345876
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      RRTCRCRFGR CFRRESYGSC NINGRIFSLC CR 
//

